Table 1 Study patient population and clinical outcome
Subject # | Age | Sex | Tumor Subtype | Therapy duration (days) | Survival (days) |
|---|---|---|---|---|---|
14 | 67 | F | Clear Cell | 1518 | 1687 |
24 | 62 | M | Clear Cell | 565 | 1040 |
20 | 63 | M | Clear Cell | 1390 | 1390 |
5 | 60 | M | Clear Cell | 56 | 480 |
2 | 50 | M | Mixed | 9 | 2399 |
21 | 59 | M | Clear Cell | 1145 | 1390 |
22 | 65 | M | Papillary | 205 | 347 |
19 | 57 | M | Clear Cell | 84 | 262 |
23 | 67 | F | Papillary | 1064 | 1207 |
25 | 71 | M | Clear Cell | 27 | 27 |
18 | 76 | F | Clear Cell | 10 | 216 |
9 | 72 | F | Mixed | 33 | 98 |
15 | 86 | F | Clear Cell | 25 | 142 |
16 | 59 | M | Clear Cell | 29 | 183 |
11 | 70 | M | Chromophobe | 735 | 1756 |
17 | 68 | M | Clear Cell | 118 | 463 |
6 | 61 | M | Clear Cell | 400 | 1519 |
8 | 76 | M | Clear Cell | 133 | 791 |
10 | 69 | M | Clear Cell | 141 | 803 |
4 | 82 | F | Unknown | 30 | 544 |